PELVIC ORGAN PROLAPSE: RISK FACTORS AND PREVENTION OPPORTUNITIES
Abstract
Pelvic organ prolapse is an urgent problem in women of different age groups, the disease tends only to increase in prevalence, and the frequency of postoperative complications increases. The nature of the clinical course of the disease and the need for repeated surgical interventions significantly reduce women's quality of life. A possible solution to the problem may be the development of measures for the primary prevention of genital prolapse.Purpose: to conduct an analytical review of the data of domestic and foreign literature on the etiopathogenetic foundations of genital prolapse, its risk factors and the possibilities of influencing them in order to develop preventive measures.Material and methods. Analysis of foreign and domestic literature.Results and conclusions. According to many foreign and domestic authors, traumatic vaginal childbirth is the main risk factor for genital prolapse. Reducing birth injuries in women at high risk of genital prolapse may be a promising direction in the development of primary measures for the prevention of the disease.
About the Authors
P. A. Berg
ФГБОУ ВО «Башкирский государственный медицинский университет» Минздрава России
Russian Federation
Russian Federation
A. G. Yaschuk
ФГБОУ ВО «Башкирский государственный медицинский университет» Минздрава России
Russian Federation
Russian Federation
I. I. Musin
ФГБОУ ВО «Башкирский государственный медицинский университет» Минздрава России
Russian Federation
Russian Federation
Yu. N. Fatkullina
ФГБОУ ВО «Башкирский государственный медицинский университет» Минздрава России
Russian Federation
Russian Federation
E. A. Berg
ФГБОУ ВО «Башкирский государственный медицинский университет» Минздрава России
Russian Federation
Russian Federation
References
1. Culligan, P.J. Nonsurgical management of pelvic organ prolapse / P.J. Culligan // Obstet. Gynecol. - 2012. - Vol. 119, № 4. - P. 852-860.
2. Iglesia, C.B. Pelvic Organ Prolapse / C.B. Iglesia, K.R.Smithling// Am Fam Physician.- 2017.- Vol. 96, №3.- Р:179-185. PMID: 28762694.
3. Management of pelvic organ prolapse and quality of life: a systematic review and meta-analysis / M. Doaee [et al.] // Int. Urogynecol. J. - 2014. - Vol. 25, № 2. - P. 153-163.
4. Barber, M.D. Pelvic organ prolapse. / M.D.Barber // BMJ.- 2016.- Jul 20.-354.-Р :i3853. doi: 10.1136/bmj.i3853. PMID: 27439423.
5. Magnetic resonance defecography versus clinical examination and fluoroscopy: a systematic review and meta-analysis / L. Ramage [et al.] // Tech. Coloproctol. - 2017. - Vol. 21, № 12. - P. 915-927.
6. Mattsson, N.K. Pelvic organ prolapse surgery and quality of life-a nationwide cohort study/ N.K. Mattsson [et al.]// Am J Obstet Gynecol.- 2020.- Vol.222, №6.-Р:588.
7. Pelvic Organ Prolapse / American College of Obstetricians and Gynecologists and the American Urogynecologic Society //. Female Pelvic Med Reconstr Surg. -2019.- Vol.25, №6.-P 397-408.
8. Dietz, H.P. Pelvic organ prolapse - a review. / H. P. Dietz //Aust Fam Physician.- 2015.-Vol.44, №7.-P:446-52.
9. Vergeldt TF, Weemhoff M, IntHout J, Kluivers KB. Risk factors for pelvic organ prolapse and its recurrence: a systematic review.Int Urogynecol J. 2015 Nov;26(11):1559-73. doi: 10.1007/s00192-015-2695-8. Epub 2015 May 13. PMID: 25966804; PMCID: PMC4611001.
10. Comparison of the vault prolapse rate after vaginal hysterectomy with or without residual uterine ligament ligations: a retrospective cohort study / P.C. Wu [et al.] //j. Formos. Med. Assoc. - 2020. - Vol. 119, № 4. - P. 805-812.
11. Prevalence and trends of symptomatic pelvic floor disorders in U.S. women /j.M. Wu [et al.] // Obstet. Gynecol. - 2014. - Vol. 123, № 1. - P. 141-148.
12. Forecasting the prevalence of pelvic floor disorders in U.S. women: 2010 to 2050 /j.M. Wu [et al.] // Obstet. Gynecol. - 2009. - Vol. 114, № 6. - P. 1278-1283.
13. Fatton B, de Tayrac R, Letouzey V, Huberlant S. Pelvic organ prolapse and sexual function. Nat Rev Urol. 2020 Jul;17(7):373-390. doi: 10.1038/s41585-020-0334-8. Epub 2020 Jun 17. PMID: 32555435.
14. Hallock, J.L. The epidemiology of pelvic floor disorders and childbirth: an update /j.L. Hallock, V.L. Handa // Obstet. Gynecol. Clin. North Am. - 2016. - Vol. 43, № 1. - P. 1-13.
15. Ramalingam, K. Obesity and pelvic floor dysfunction / K. Ramalingam, A. Monga // Best Pract. Res. Clin. Obstet. Gynaecol. - 2015. - Vol. 29, № 4. - P. 541-547.
16. de Sam Lazaro, S. Obesity and pelvic floor dysfunction: battling the bulge / S. de Sam Lazaro, R. Nardos, A.B. Caughey // Obstet. Gynecol. Surv. - 2016. - Vol. 71, № 2. - P. 114-125.
17. A systematic review of clinical studies on hereditary factors in pelvic organ prolapse / S.L. Lince [et al.] // Int. Urogynecol. J. - 2012. - Vol. 23, № 10. - P. 1327-1336.
18. Are women with pelvic organ prolapse at a higher risk of developing hernias? / Y. Segev [et al.] // Int. Urogynecol. J. Pelvic Floor Dysfunct. - 2009. - Vol. 20, № 12. - P. 1451-1453.
19. Association between joint hypermobility and pelvic organ prolapse in women: a systematic review and meta-analysis / N. Veit-Rubin [et al.] // Int. Urogynecol. J. - 2016. - Vol. 27, № 10. - P. 1469-1478.
20. Dieter AA. Pelvic Organ Prolapse: Controversies in Surgical Treatment. Obstet Gynecol Clin North Am. 2021 Sep;48(3):437-448. doi: 10.1016/j.ogc.2021.05.001. PMID: 34416930.
21. Risk factors for pelvic organ prolapse and its recurrence: a systematic review / T.F. Vergeldt [et al.] // Int. Urogynecol. J. - 2015. - Vol. 26, № 11. - P. 1559-1573.
22. Raju R, Linder BJ. Evaluation and Management of Pelvic Organ Prolapse. Mayo Clin Proc. 2021 Dec;96(12):3122-3129. doi: 10.1016/j.mayocp.2021.09.005. PMID: 34863399.
23. Khunda, A. Can ballooning of the levator hiatus be determined clinically? / A. Khunda, K.L. Shek, H.P. Dietz // Am. J. Obstet. Gynecol. - 2012. - Vol. 206, № 3. - P. 246.e1-4.
24. Risks of stress urinary incontinence and pelvic organ prolapse surgery in relation to mode of childbirth / A. Leijonhufvud [et al.] // Am. J. Obstet. Gynecol. - 2011. - Vol. 204, № 1. - P. 70.e1-7.
25. Pelvic floor disorders after vaginal birth: effect of episiotomy, perineal laceration, and operative birth / V.L. Handa [et al.] // Obstet. Gynecol. - 2012. - Vol. 119, № 2 Pt 1. - P. 233-239.
26. Age-related pelvic floor modifications and prolapse risk factors in postmenopausal women / A. Tinelli [et al.] // Menopause. - 2010. - Vol. 17, № 1. - P. 204-212.
27. Sze, E.H.M. A prospective cohort study of pelvic support changes among nulliparous, multiparous, and pre- and post-menopausal women / E.H.M. Sze, G. Hobbs // Eur. J. Obstet. Gynecol. Reprod. Biol. - 2012. - Vol. 160, № 2. - P. 232-235.
28. Weintraub AY, Glinter H, Marcus-Braun N. Narrative review of the epidemiology, diagnosis and pathophysiology of pelvic organ prolapse.Int Braz J Urol. 2020 Jan-Feb;46(1):5-14. doi: 10.1590/S1677-5538.IBJU.2018.0581. PMID: 31851453; PMCID: PMC6968909.
29. Short-term urogenital effects of raloxifene, tamoxifen, and estrogen / M.D. Vardy [et al.] // Am. J. Obstet. Gynecol. - 2003. - Vol. 189, № 1. - P. 81-88.
30. Albertazzi, P. Urogenital effects of selective estrogen receptor modulators: a systematic review / P. Albertazzi, S. Sharma // Climacteric. - 2005. - Vol. 8, № 3. - P. 214-220.
31. Nordstrom BL, Cai B, De Gregorio F, Dhalwani N, Fraeman KH, Yoshida Y, Gibbs T. Incidence of venous thromboembolism among postmenopausal women prescribed ospemifene, selective estrogen receptor modulators for noncancer indications, or untreated vulvar and vaginal atrophy. Menopause. 2020 Aug;27(8):864-871. doi: 10.1097/GME.0000000000001552. PMID: 32404795.
32. Filimonov VB, Vasin RV, Vasina IV, Kaprin AD, Kostin AA. [Female genital prolapse surgery using ultra lightweight polypropylene mesh]. Urologiia. 2017 Jun;(2):14-23.Russian. doi: 10.18565/urol.2017.2.14-23. PMID: 28631901.
33. Sensitivity of the fasciae to sex hormone levels: modulation of collagen-I, collagen-III and fibrillin production / C. Fede [et al.] // PLoS One. - 2019. - Vol. 14, № 9. - P. e0223195.
34. Dökmeci F, Tekşen F, Çetinkaya ŞE, Özkan T, Kaplan F, Köse K. Expressions of homeobox, collagen and estrogen genes in women with uterine prolapse. Eur J Obstet Gynecol Reprod Biol. 2019 Feb;233:26-29. doi: 10.1016/j.ejogrb.2018.11.019. Epub 2018 Nov 29. PMID: 30550979.
35. He K, Niu G, Gao J, Liu JX, Qu H. MicroRNA-92 expression may be associated with reduced estrogen receptor β1 mRNA levels in cervical portion of uterosacral ligaments in women with pelvic organ prolapse. Eur J Obstet Gynecol Reprod Biol. 2016 Mar;198:94-99. doi: 10.1016/j.ejogrb.2016.01.007. Epub 2016 Jan 11. PMID: 26803387.
Review
For citations:
Berg P.A., Yaschuk A.G., Musin I.I., Fatkullina Yu.N., Berg E.A. PELVIC ORGAN PROLAPSE: RISK FACTORS AND PREVENTION OPPORTUNITIES. Bashkortostan Medical Journal. 2022;17(1):83-88. (In Russ.)
Views:
82
Email this article 
